The emergence of drugs like copyright and Semaglutide signifies a remarkable shift in how we approach blood sugar. These new therapies belong to a class known as GLP-1 action agonists, which replicate the effects of a natural hormone that controls blood sugar levels and appetite. Initially, developed for diabetes, their effectiveness in promotin… Read More